What is PT141 ?
PT-141 (Bremelanotide)is a centrally acting melanocortin receptor agonist used to enhance sexual desire and arousal in both men and women. Originally developed to treat sexual dysfunction, it is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women and is also commonly used off-label in men with low libido or erectile dysfunction—especially when psychological or central causes are suspected. Unlike traditional ED medications, PT-141 works through the brain rather than blood flow.
Benefits
- Increases sexual desire in men and women
- Effective for psychological and neurological libido issues
- Can help men with ED unresponsive to PDE5 inhibitors
- Enhances physical arousal, sensation, and orgasmic response
- FDA-approved for HSDD in women
- Non-hormonal and well tolerated